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Diffuse proliferative lupus nephritis: Identification of specific patholog-
ic features affecting renal outcome. Prerandomization renal biopsy
specimens were examined in 102 patients upon entry into prospective
therapeutic trials of lupus nephntis in an attempt to identify early
predictors of renal failure outcome. All 11 renal failures occurred
among the 72 individuals with diffuse proliferative or membranoproli-
ferative glomerulonephritis (DPGN/MPGN); thus, these patients were
at modestly, but significantly, increased risk of endstage renal disease
compared to those with focal proliferative, membranous, or mesangial
glomerulonephritis. Considering the low incidence of endstage renal
disease among patients with DPGN/MPGN, we sought to refine the
prognostic information obtained from renal morphology by semiquanti-
tative scoring of individual histologic features and by derivation of
composite histologic scores specified by Activity (Al) and Chronicity
(CI) Indices. Among the 72 patients with DPGN/MPGN, the composite
AL was more strongly predictive of renal failure than were the individual
active histologic features; cellular crescents and extensive fibrinoid
necrosis yielded positive associations, while endocapillary prolifera-
tion, leucocytic exudation, and hyaline thrombi in glomeruli and
interstitial inflammation by themselves did not emerge as useful prog-
nostic indicators. However, chronicity items (glomerular sclerosis,
fibrous crescents, tubular atrophy, and interstitial fibrosis) considered
individually, as well as in the composite CI, were highly predictive of
renal failure outcome. Particularly striking was the prognostic value of
tubular atrophy; all 11 renal failures were among the 43 patients with
tubular atrophy on prerandomization renal biopsy. While no single
pathologic variable improved outcome predictions among those with
tubular atrophy, examination for interactions among variables revealed
that glomerular sclerosis and cellular crescents had a synergistic effect
which augmented the prognostic information derived from analysis of
tubular atrophy alone. Thus, the simultaneous occurrence of tubular
atrophy, glomerular sclerosis, and cellular crescents identified a very
high-risk group; six of nine patients progressed to endstage renal
disease within 4 years of study entry. In conclusion, semiquantitative
scoring of individual histologic features can refine estimates of the risk
of renal failure in lupus patients with DPGN or MPGN.
Néphrite lupique proliferative diffuse: Identification de caracteristiques
pathologiques spécifiques affectant l'évolution rénale. Les specimens
biopsies rénales de 102 malades avant randomisation ont été examinées
a l'entrée dans des essais therapeutiques prospectifs de Ia néphrite
lupique, destinés a identifier les facteurs prédictifs precoces de sur-
venue d'une insuffisance rénale. La totalité des 11 insuffisances rénales
est survenue parmi les 72 sujets atteints d'une glomérulonephrite diffuse
proliferative ou membrano-proliferative (DPGN/MPGN); ainsi, ces
malades avaient un risque modérément, mais significativement, accru
de nephropathie terminale, par rapport a ceux atteints d'une gloméru-
lonéphnte proliferative focale, extramembraneuse ou mesangiale. En
considérant Ia faible incidence d'une néphropathie terminale parmi les
patients atteints de DPGN/MPGN, nous avons cherchC a affiner l'infor-
mation pronostique obtenue a partir de Ia morphologie rénale par un
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score semiquantitatif des caractéristiques histologiques individuelles et
par des scores histologiques composites dérivés spéciflés par des Index
d'ActivitC (Al) et de Chronicité (CI). Parmi les 72 malades atteints de
DPGN/MPGN, l'AI composite était plus fortement prédictif d'une
insuffisance rCnale que les caracteristiques histologiques actives indivi-
duelles; les croissants cellulaires et une nécrose fibrinoide étendue
donnaient des associations positives, alors que Ia proliferation endoca-
pillaire, l'exsudation leucocytaire et des thrombus hyalins dans les
glomerules, ainsi que l'inflammation interstitielle en eux-mêmes, n'ap-
paralssaient pas comme des indicateurs utiles de pronostic. Cependant,
les items de chronicité (sclérose glomerulaire, croissants fibreux,
atrophie tubulaire, et fibrose interstitielle) considáerCs individuelle-
ment, ainsi que dans le CI composite, étaient hautement predictifs de La
survenue d'une insuffisance rénale. ParticuliCrement frappante était Ia
valeur pronostique de l'atrophie tubulaire; les II insuffisances rénales
étaient parmi les 43 malades ayant une atrophie tubulaire a Ia biopsie
ráenale prérandomisation. Alors qu'aucune variable pathologique iso-
lee n'améliorait les predictions sur le devenir parmi ceux atteints
d'atrophie tubulaire, l'examen des interactions entre variables a révélé
que Ia sclérose glomCrulaire et les croissants cellulaires avaient un effet
synergistique qui augmentait l'information pronostique obtenue a partir
de l'analyse de l'atrophie tubulaire seule. Ainsi, l'appantion simultanée
d'une atrophie tubulaire, d'une sclérose glomerulaire et de croissants
cellulaires identiflait a un groupe a trés haut risque; six de neuf malades
ont progressC vers une nCphropathie terminale dans les quatre ans
suivant l'entrCe dans l'étude. En conclusion, un score semiquantitatif
des caracteristiques histologiques individuelles peut raffiner les estima-
tions du risque d'insuffisance rénale chez des malades lupiques atteints
de DPGN ou de MPGN.
The highly variable nature of lupus nephritis has prompted
investigation of prognostic features that would permit identifi-
cation of those at high risk of renal failure. The renal histologic
classification system described by Pollak, Pirani, and Kark [1],
and Pollak, Pirani, and Schwartz [2] and later modified by
Baldwin et al [3] was an important contribution; diffuse prolifer-
ative glomerulonephritis (DPGN) appeared to be a particularly
ominous finding. While some investigators concur that DPGN
is a strong prognostic indicator [1—81, others have not confirmed
this observation [9—15]. The variable clinical outcomes of
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patients with DPGN weaken the predictive value of this classifi-
cation and reflect, in part, the pathologic heterogeneity encoun-
tered within this subgroup [16, 17]. Recognition of DPGN is
based primarily on the extent of endocapillary proliferation but
also incorporates features of necrosis, sclerosis, and capillary
loop thickening.
The clinical course of patients with DPGN is probably
influenced by the variable occurrence of certain histologic
features not specified by the conventional classification system
of lupus nephritis. Thus, detailed description of active and
chronic, irreversible pathologic lesions affecting glomeruli, tu-
bules, interstitium, and vasculature could augment the prognos-
tic information derived from histologic classification and permit
recognition of those patients with DPGN at high risk of end-
stage renal disease.
To address this issue, a semiquantitative scoring system was
used to examine the prognostic value of individual types of
histologic lesions as well as of composites of activity and
chronicity features of renal biopsy specimens among patients
with DPGN and membranoproliferative glomerulonephritis
(MPGN).
Methods
Early histologic predictors of renal failure were sought among
111 entrants into long-term prospective therapeutic trials of
lupus nephritis at the National Institute of Arthritis, Diabetes,
and Digestive and Kidney Diseases (NIADDK) from 1969 to
1980. Prerandomization renal biopsy specimens adequate for
detailed light microscopic examination were available on 102
patients who were thus included in the present analysis. The
clinical studies have been reported elsewhere [18—23]. Admis-
sion criteria included: (1) a diagnosis of systemic lupus erythe-
matosus as specified by the American Rheumatism Association
[24]; (2) reproducible clinical evidence of active glomerulone-
phritis; (3) creatinine clearance greater than 20 ml/min; (4) no
cytotoxic drug therapy within 8 weeks prior to potential study
entry; and (5) informed consent to all aspects of the study. For
their own protection, patients with any one of the following
were excluded from a therapeutic trial: (1) major infection
within 2 weeks, (2) pregnancy, or (3) sensitivity to a study drug.
Renal histology
Specimen preparation. For light microscopy, specimens
were fixed in B5 (buffered formaldehyde-mercuric chloride)
solution for 2 to 4 hr and paraffin-embedded tissue was cut at 4
. Conventional hematoxylin-eosin, periodic acid Schiff (PAS),
and Masson's trichrome stains were utilized. For electron
microscopy, tissue samples were fixed in 2.5% buffered glutar-
aldehyde, postfixed in 1% osmium tetroxide, dehydrated in
graded alcohol, and embedded in epoxy resin. Ultrathin sec-
tions were stained with uranyl acetate and lead citrate.
Conventional class(fication. World Health Organization
(WHO) criteria were used for the light microscopy classification
of the major forms of lupus nephritis [25]. Briefly, DPGN was
recognized by combinations of endocapillary proliferation, ne-
crosis, sclerosis, and capillary 1oop thickening in more than
50% of glomeruli. The subset of biopsy specimens with MPGN
exhibited diffuse lobular hypercellularity with a narrowing of
capillary lumina and/or subendothelial mesangial extension
causing double contours.
Refinement of the description of biopsy specimens within the
pathologic spectrum of DPGN and MPGN was approached
using a modification of a previously reported system [26]
involving semiquantitative scoring of specific biopsy features to
be described individually below. A scale of 0, 1, 2, or 3+
applied to each item generally corresponded to absent, mild,
moderate and severe, respectively, for biopsy specimens in
which six or more glomeruli were examined. The nephropatho-
logist and the nephrologist independently graded the morpho-
logic alterations without knowledge of the patients' clinical
course. Consistent with previous experience [27, 28], assigned
scores rarely differed by more than one point. Discrepancies
were resolved by arbitrarily employing the higher grade.
Glomerular cell proliferation. This feature indicated the
degree of glomerular endocapillary hypercellularity (mesangial,
endothelial, and possibly infiltrating monocytes) leading to
reduction of circulatory volume of glomerular capillary loops.
The lesions were scored by the extent of loss of circulatory
space due to segmental (or global) proliferative changes in less
than 25% (1+), 25 to 50% (2+), or greater than 50% (3+) of
glomeruli.
Leucocyte exudation. Exudation of more than two polymor-
phonuclear leucocytes per glomerulus was considered abnor-
mal. Exudation was scored as mild (1+), moderate (2+), or
extensive (3+).
Karyorrhexis and fibrinoid necrosis. Karyorrhexis was de-
fined by the presence of pyknotic and fragmented nuclei.
Fibrinoid necrosis was identified by the occurrence of intensely
eosinophilic material within solidified segments of glomeruli.
Fibrinoid necrosis was usually confirmed by Masson stain and
was typically accompanied by karyorrhexis in involved glomer-
uli. The following scale of severity was used: karyorrhexis only
or fibrinoid necrosis in less than 25% of glomeruli (1+),
fibrinoid necrosis in 25 to 50% (2+) or greater than 50% (3+) of
glomeruli. The assigned score was weighted by a factor of two
[2] because such lesions were considered to be disproportion-
ately severe as previously suggested [29].
Cellular crescents. Proliferating extracapillary cells occupy-
ing one-fourth or more of the glomerular capsular circumfer-
ence were considered cellular crescents. Determination of the
predominant component of crescents (cellular or fibrous) was
assisted by Masson staining. The crescent score was defined as
follows: cellular crescents in less than 25% (1+), 25 to 50%
(2+), or greater than 50% (3+) of glomeruli. The assigned score
was weighted by a factor of two [2] because such lesions were
considered to be disproportionately severe [29].
Hyaline deposits. Eosinophilic material of a homogenous
consistency along the circumference of the luminal surface of
glomerular capillaries constituted the classical wire 1oop lesion.
More extensive globular material occupying entire capillary
loops were identified as hyaline thrombi. The hyaline material
was considered to represent massive accumulation of immune
complexes. Hyaline lesions were scored as few (1+), moderate
(2+), or extensive (3+).
Interstitial inflammation. Infiltration of mononuclear cells
(lymphocytes, plasma cells, macrophages) into interstitial
spaces was assigned scores of mild (1+), moderate (2+), or
extensive (3+).
Glomerular sclerosis. Glomerular capillary collapse with
attendant expansion of mesangial matrix material and subse-
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quent solidification was observed in both segmental and global
patterns. Solidification occurring only segmentally or in global
patterns in less than 25% (1+) of glomeruli, and global sclerosis
in 25 to 50% (2+) or greater than 50% (3+) of glomeruli were
designated.
Fibrous crescents. Structures composed predominantly or
exclusively of fibrous tissue lining Bowman's capsule in a
circumferential pattern were considered fibrous crescents. The
crescent scores were defined as follows: fibrous crescents in
less than 25% (1+), 25 to 50% (2+) or greater than 50% (3+) of
glomeruli.
Tubular atrophy. Atrophic changes were identified by the
thickening of tubular basement membranes, with or without
tubular epithelial cell degeneration. Separation of residual tu-
bules was typically observed. The severity of tubular atrophy
was designated as mild (1+), moderate (2+), or extensive (3+).
Interstitial fibrosis. The deposition of periglomerular and
peritubular fibrous tissue was judged primarily by the Masson
stain. The severity of interstitial fibrosis was designated as mild
(1+), moderate (2+), or extensive (3+).
Activity Index (Al). This index was defined as the sum of
individual scores of the following items considered to represent
measures of active lupus nephritis: glomerular proliferation,
leucocyte exudation, karyorrhexis/fibrinoid necrosis (x2), cel-
lular crescents (x2), hyaline deposits, and interstitial inflamma-
tion. The maximum score was 24 points for the Activity Index.
Chronicity Index (Cl). This index consisted of the sum of
individual scores of the following items considered to represent
measures of chronic irreversible lupus nephritis: glomerular
sclerosis, fibrous crescents, tubular atrophy, and interstitial
fibrosis. The maximum score was 12 points for the Chronicity
Index.
Electron microscopy. Generally two or three glomeruli were
examined in each biopsy specimen. For the present study the
location and extent of electron dense deposits were quantitated
on a scale of 0 to 4+, corresponding to a range of absent to
massive. The deposits present in each of the following five
locations were individually scored: mesangial, subendothelial,
subepithelial, intramembranous, and extraglomerular (peritubu-
lar and/or perivascular). In addition to immune deposit analysis,
the presence or absence of tubuloreticular structures was noted
in endothelial cells.
Statistical analysis
To determine the predictive value of various histologic fea-
tures, computer-assisted survival analysis used the time inter-
val from study entry to endstage renal disease as the measure of
outcome. Since the precise time to failure is unknown for those
who have yet to experience the terminal event, statistical
methods appropriate for the analysis of censored data were
used [30—32].
Light and electron microscopic features were individually
tested for prognostic significance using renal failure rate as the
criterion (Table 1). This rate was defined as the number of renal
failures per 1000 patient-months of observation. The renal
failure rate was calculated at each level of pathologic variables,
and contiguous subgroups with similar failure rates were com-
bined. The prognostic value of variables subdivided into three
or more groups was determined by the "score test" of trend
[33], which is similar to a test for the trend in a simple linear
regression. For variables with only two levels, the trend test
simplifies to one similar to a Student's t test of means.
The predictive value of various histologic features of lupus
nephritis was further examined by cumulative survival curves
derived by the Kaplan-Meier method [34]. Thus, the estimate of
survival probability was recalculated at each unique time of
renal failure. The equality of survival curves obtained for
different subgroups of patients was tested employing two statis-
tics appropriate for censored data: the Gehan [35] and the
Mantel-Haenszel [36]. The Gehan test is more sensitive to early
failures than the Mantel-Haenszel test.
Results
Histologic features of lupus nephritis were examined in 102
patients in an attempt to identify early prognostic indicators of
renal failure (median follow-up, 53 months). At study entry, the
median age was 27 years, and lupus nephritis had been clinically
evident for a median of 9 months. There were 15 males and 87
females. Employing WHO histologic criteria, the prerandomi-
zation renal biopsy specimens were classified as follows: 60
diffuse proliferative (DPGN), 12 membranoproliferative
(MPGN), 7 focal proliferative, 16 membranous, and 7 mesangial
glomerulonephritis.
All 11 patients experiencing renal failure were among the 72
patients who had DPGN (ten failures) or MPGN (one failure);
hence this combined group was at modestly, but significantly,
increased risk of endstage renal disease compared to those with
focal proliferative, membranous, or mesangial glomerulone-
phritis (Fig. 1). However, the infrequent occurrence of renal
failure among patients with DPGN or MPGN weakens these
classifications as prognostic indicators. Thus, analyses were
done to determine which patients with DPGN or MPGN were at
high risk of renal failure. The predictive value of individual
histologic features, as well as composite scores, specified by
Activity and Chronicity Indices, were examined in the 72
patients classified as having DPGN or MPGN.
Figure 2 illustrates the predictive value of extensive active
histologic change. Patients with Activity Indices (Al) greater
than or equal to 12 were at a significantly increased risk of
endstage renal disease compared to those with lower Activity
Indices. At the end of a 4-year observation, the estimated
probability of renal failure outcome in the high risk group was
40% compared to 7% for the low risk group.
In contrast to Al, the Chronicity Index (CI) appeared to have
a graded impact on prognosis permitting identification of pa-
tients with low, intermediate, and high rates of renal failure
(Fig. 2). While endstage renal disease has yet to occur in the 29
patients with little or no chronic histologic change (CI 1), the
renal failure rate was significantly increased among patients
with mid- or high-range Chronicity Indices.
To derive additional prognostic information from renal mor-
phology, renal failure rates were calculated for groups with
different types of individual histologic features as described in
Methods (Table 1). In general, the composite Al was more
strongly predictive than individual active features of the biopsy
specimen. Patients with cellular crescents showed a moderate
elevation of the renal failure rate. In addition, two of three
patients with severe fibrinoid necrosis failed quickly (28 and 31
months). The four persons who failed either without cellular
crescents or without fibrinoid necrosis all had chronic tubuloin-
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Table 1. Renal failure rates by levels of prognostic factors for 72 patients with diffuse or membranoproliferative glomerulonephritis
Prognostic factor Numbera Failuresb Ratea Pvalued Prognostic factor Numbera Failuresb Ratec Pvalued
Composite Pathologic Scores Fibrous crescents 0.028
Activity Indexa 0.048 None 55 6 1.68
Low/mid 55 6 1.72 Mild/severe 17 5 5.86
High 17 5 5.35 Tubular atrophy 0.004
Chronicity Index 0.0003 None 29 0 0.00
Low 29 0 0.0 Mild/severe 43 II 4.41
Mid 23 4 2.67 Interstitial fibrosis 0.004
High 20 7 7.25 None
Mild
26
36
1
6
0.52
3.03
Individual light microscopy Mod/severe 10 4 7.50
features
Proliferation 0.941 Electron microscopy
None/mild 6 0 0.0 deposits
Moderate 55 10 2.84 Mesangial 0.425
Severe 11 1 1.58 Absent 1 0 0.0
Leucocytes 0.667 Mild 6 2 5.58
None 37 6 2.78 Moderate 17 3 3.00
Mild 27 4 2.33 Extensive 21 2 1.76
Mod/severe 8 1 1.83 Massive 2 0 0.0
Necrosis 0.858 Subendothelial 0.337
None 11 3 4.25 Absent 17 3 3.09
Mild 34 4 1.90 Mild 9 2 4.67
Moderate 24 2 1.34 Moderate 15 2 1.85
Severe 3 2 16.26 Extensive/massive 6 0 0.0
Cellular crescents 0.113 Subepithelial 0.981
None 43 4 1.56 Absent 10 1 1.82
Mild 18 4 3.20 Mild 15 3 2.98
Mod/severe 11 3 4.84 Moderate 14 2 2.96
Hyaline deposits 0.979 Extensive 8 1 1.95
None 29 5 2.65 Intramembranous 0.284
Mild 20 2 1.46 Absent 21 2 1.49
Moderate 16 4 4.92 Mild/extensive 26 5 3.56
Severe 7 0 0.0 Extraglomerular
Interstitial Inflammation 0.972 deposits 0.306
None 9 1 1.90 Absent 32 4 1.97
Mild 34 5 2.78 Mild/moderate 15 3 4.22
Mod/severe 29 5 2.38 Tubuloreticular
Glomerular sclerosis 0.024 structures 0.5 17
None 43 4 1.42 Absent 14 3 3.47
Mild 19 4 3.33 Present 33 4 2.18
Mod/severe 10 3 7.21
a The number of patients with the specified level of a histologic variable are listed.
b The numbers listed reflect the numbers of patients progressing to renal failure in each pathologic subset.
a The renal failure rate equals the number of renal failures/l000 patient-months of follow-up (see Statistical analysis).
d The P value exhibits the significance level for the "score test" of equality or of the trend of renal failure rates (see Statistical analysis).
Adjacent levels of a prognostic factor that have similar renal failure rates were combined.
For each variable in this group there were 25 patients with unknown values; this group had four with renal failure with a rate of 2.38/1000
patient-months.
terstitial disease. Little prognostic information could be derived
from the presence or extent of endocapillary proliferation,
leucocytic exudation, or hyaline thrombi in glomeruli, or inter-
stitial inflammation.
Different from the active histologic features, each individual
chronic pathologic variable (glomerular sclerosis, fibrous cres-
cents, tubular atrophy, and interstitial fibrosis) was associated
with an increased risk of endstage renal disease. Particularly
striking was the predictive value of tubular atrophy. All 11 renal
failures occurred among the 43 patients with this finding in
prerandomization renal biopsy specimens. While tubular atro-
phy clearly identified a high-risk group, most of its members
have yet to fail. Hence, additional individual histologic features
were considered in an effort to enhance outcome predictions
based on tubular atrophy alone. Relatively strong prognostic
indicators affecting glomeruli (Table 1) were tested for predic-
tive value in the tubular atrophy group using the renal failure
rate as the criterion (interstitial fibrosis was nearly always
associated with tubular atrophy and thus contributed little
additional prognostic information). Cellular crescents, glomeru-
lar sclerosis, and fibrous crescents were examined individually
and in pair combinations as dichotomous variables. Considered
individually, the three variables failed to improve outcome
prediction for patients manifesting tubular atrophy. On the
other hand, the simultaneous occurrence of cellular crescents
and glomerular sclerosis placed patients with tubular atrophy at
a particularly high risk of renal failure (Fig. 3 1371). Thus, in the
presence of tubular atrophy, the combination of cellular cres-
cents and glomerular sclerosis had a synergistic impact on
outcome. While this interaction was recognized employing
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Fig. 1. Cumulative survival curves demonstrating the probability of
maintaining life-supporting renal function in patients with diffuse
proliferative or membranoproliferative lupus nephritis (DPGN/MPGN)
compared to other patients with focal proliferative, membranous, or
mesangial lupus nephritis (Other). Numbers on the curves indicate the
number of patients in the group that remains at risk.
relativelyuncomplicated statistical methods, the Cox multivari-
ate survival analysis [38] confirmed the observation (details not
included).
Figure 3 depicts cumulative survival curves for
DPGN/MPGN patients with the combination of tubular atro-
phy, cellular crescents, and glomerular sclerosis (N = 9)
compared to all other DPGN/MPGN patients who lacked such a
combination of unfavorable prognostic features (N = 63). Six of
nine persons affected by all three factors progressed to endstage
renal disease within 4 years, resulting in significantly different
renal function survival probabilities for groups defined in this
manner. Because of the a posteriori manner in which the groups
were selected, the significance levels portrayed in Figure 3
should be interpreted cautiously.
The prognostic information derived from electron microsco-
py was limited in part by the lack of data for 25 patients,
including four who progressed to renal failure. Of the electron
microscopic features depicted in Table I, intramembranous
deposits (IM) appeared most informative, and further analysis
of each electron microscopic variable employing cumulative
survival curves confirmed this impression. Of interest, all five
patients with renal failure in the IM subgroup failed within 4
years of study entry, whereas the two in the non-IM subgroup
developed after longer follow-up periods (67 and 94 months).
Using the Gehan test, which is relatively more sensitive to early
events, suggestive evidence was obtained that patients with
intramembranous deposits were at an increased risk of early
renal failure outcome (P = 0.083). Noteworthy is the associa-
tion between scores of intramembranous deposits and of
glomerular sclerosis (Pearson chi-square, x2 = 13.27, 6 df, P =
0.039).
Discussion
The present study examined the hypothesis that semiquanti-
tative scoring of individual histologic features of lupus nephritis
29 25
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Fig. 2. Cumulative survival curves based on 72 lupus patients with
DPGN or MPGN demonstrating the prognostic impact of the Activity
(Al) and Chronicity (CI) Indices on the probability of maintaining life-
sustaining renal function. Numbers on the curves indicate the number
of patients in the group that remains at risk. For calculation of Al,
cellular crescents and necrosis were weighted by a factor of two. IA
composite activity score derived ascribing equal weight to all active
histologic features revealed similar prognostic information; a score
greater than or equal to ten identified patients at an increased risk of
renal failure compared to those with lower scores (Gehan, P = 0.023;
Mantel-Haenszel, P = 0.038).]
could augment the prognostic information obtained by renal
pathology classification, While conventional classification
schemes yield valuable information, it is inevitable that differ-
ences among patients will be obscured by categorizing the
diverse histologic lesions of lupus nephritis into a small number
of classes. The system lacks sufficient flexibility and detail to
describe completely the highly variable renal pathology encoun-
tered [16, 17]. The problem is particularly striking among
patients classified as having DPGN or MPGN, wherein the
same histologic label is applied to an especially broad range of
694 Austin et aI
C I
0 20 40 60 80 100 120 140
Follow-up, months
Fig. 3. Cumulative survival curves based on 72 lupus patients with
DPGN or MPGN demonstrating the probability of maintaining life-
supporting renal function in high- and low-risk groups identified
according to the individual histologic features tubular atrophy, glomer-
ular sclerosis, and cellular crescents. The high-risk group consists of
individuals whose prerandomization renal biopsy specimens reflected
the presence of all three pathologic variables. Survival estimates are
subject to increased error when few patients remain under observation
indicated by numbers on the curves. The 95% confidence limits for the
high-risk group were (0.365, 0.939), (0.204, 0.805), and (0.051, 0.576) at
24, 36, and 48 months, respectively [371.
marked elevations in Al, cellular crescents, and severe fibrinoid
necrosis, foretold an unfavorable outcome. We suggest that
these results indicate a tendency for such fulminant active
lesions to be associated with subsequent sclerosis and perma-
nent loss of functional renal tissue. Other, less severe, active
lesions are potentially reversible and thus, may be relatively
weak predictors of long-term renal function outcome.
Among the individual histologic variables tested for prognos-
tic significance, tubular atrophy emerged as particularly impor-
tant. All 11 renal failures occurred among the 43 patients
manifesting tubular atrophy on prerandomization renal biopsy
_____________
specimen. While this morphologic attribute clearly identified a
high-risk group, outcome predictions could be enhanced by the
simultaneous consideration of glomerular sclerosis and cellular
crescents as well as tubular atrophy. Six of nine patients with all
_______________________________________
three adverse prognostic indicators progressed to endstage
renal disease within 4 years. Thus, the presence of chronic,
irreversible lesions affecting both the glomerular and the tubular
portions of the nephron, plus the relatively ominous active
feature, cellular crescents, identified particularly high-risk
patients.
It is of interest that tubular atrophy was such a strong
prognosticator that consideration of additional single pathologic
variables failed to enhance outcome predictions among patients
with tubular atrophy. However, examination for interactions
among variables revealed that glomerular sclerosis and cellular
crescents had a synergistic impact which amplified the prognos-
tic information based on tubular atrophy alone. Therefore, in
the presence of tubular atrophy, the simultaneous occurrence of
severe active (cellular crescents) as well as chronic, irreversible
glomerular lesions (sclerosis) was of considerable prognostic
significance.
Efforts to derive prognostic information from electron mi-
croscopy were hampered, in part, by incomplete data. Of the
features examined, intramembranous deposits were modestly
associated with increased risk of early renal failure outcome.
Considering the proposed evolution of these deposits [451 and
their association with glomerular sclerosis in this study, they
appear to represent an electron microscopic expression of
chronic pathologic change.
In sum, evidence is presented supporting the hypothesis that
semiquantitative scoring of individual histologic features can
augment prognostic information derived from conventional
classification. Thus, certain heretofore little used morphologic
attributes can refine estimates of renal failure risks in patients
with DPGN or MPGN.
active and of chronic, irreversible pathologic lesions affecting
glomeruli, tubules, interstitium, and vasculature.
The diversity of clinical course observed among patients with
DPGN or MPGN underscores the need to search for prognostic
indicators that could enhance outcome predictions based solely
on renal histologic classification. Similar to previous observa-
tions [1—81, our patients with DPGN or MPGN were at a
significantly increased risk of endstage renal disease compared
to those with focal proliferative, membranous, or mesangial
glomerulonephritis. Nonetheless, the relatively low incidence
of renal failure outcome observed in patients with DPGN or
MPGN limits the predictive value of these classifications. Thus,
it is not surprising that efforts to use renal histologic classifica-
tion as a prognostic toot have led to variable results [1—15].
A number of investigators have employed semiquantitative
scoring systems to provide detailed descriptions of the diverse
pathology encountered inlupus nephritis [1, 2,8, 10, 13, 15, 27—
29, 39—441. Using such a system, the present study emphasizes
the prognostic value of specific morphologic attributes other
than the conventional classification. Among patients with
DPGN or MPGN, individual histologic features recorded at
study entry as well as the composite scores, Al and CI, were
studied by computer-assisted survival analysis using time to
renal failure as the measure of outcome.
Particularly striking was the predictive value of scierosing
lesions. CI had a graded impact on prognosis, and each individ-
ual chronic histologic feature was associated with an increased
risk of endstage renal disease. The adverse prognostic impact of
irreversible parenchymal destruction extends previous observa-
tions [13, 15, 29, 401.
Similarly, severely active pathologic change, reflected by
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